|
Apr 27
|
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
|
|
Apr 26
|
New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib
|
|
Apr 25
|
Tariffs Cast a Shadow on Abbott's 2025 View: Time to Sell ABT Stock?
|
|
Apr 24
|
EPD Growth in Emerging Market Supports Abbott Stock Amid Macro Woes
|
|
Apr 24
|
The Zacks Analyst Blog Highlights Coca-Cola, Abbott Laboratories, RTX, Investors Title and Armanino Foods of Distinction
|
|
Apr 23
|
Top Analyst Reports for Coca-Cola, Abbott & RTX
|
|
Apr 22
|
What To Expect From Penumbra’s (PEN) Q1 Earnings
|
|
Apr 22
|
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow
|
|
Apr 22
|
What To Expect From Boston Scientific’s (BSX) Q1 Earnings
|
|
Apr 21
|
Earnings To Watch: Intuitive Surgical (ISRG) Reports Q1 Results Tomorrow
|
|
Apr 20
|
Insiders At Abbott Laboratories Sold US$3.3m In Stock, Alluding To Potential Weakness
|
|
Apr 19
|
Jim Cramer Applauds Abbott Laboratories (ABT): “A Tour de Force Quarter – Robert Ford Is Keeping the Miles White Legacy Alive”
|
|
Apr 17
|
Nvidia, AMD see charges due to new China export rules: Morning Buzz
|
|
Apr 17
|
Abbott price target raised to $140 from $138 at Evercore ISI
|
|
Apr 17
|
Company News for Apr 17, 2025
|
|
Apr 17
|
Abbott Laboratories (ABT): Among the Innovative Healthcare Stocks to Watch in 2025
|
|
Apr 17
|
Abbott Laboratories (ABT) Q1 2025 Earnings Call Highlights: Strong Growth in Medical Devices ...
|
|
Apr 17
|
Q1 2025 Abbott Laboratories Earnings Call
|
|
Apr 16
|
Barclays Flags Medtronic, J&J as Most at Risk from Looming Pharma Tariffs
|
|
Apr 16
|
Hertz, Abbott Laboratories, and Interactive Brokers: Trending tickers
|